Antioxidant Effects on the Outcome of Ovarian Cancer
The subjects are randomized to 2 study groups. Group 1 receives standard chemotherapy
prescribed by the cancer doctor (carboplatin and paclitaxel)with a possible choice to extend
chemotherapy for up to an additional 12 months.
Group 2 receives standard chemotherapy in the same manner as group 1. In addition, they
receive 12 months of oral or IV nutritional supplements.
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Adverse events by NCI CTC version 3.0
At each oncology clinic visit
Jeanne A. Drisko, MD
University of Kansas
United States: Food and Drug Administration
|University of Kansas Medical Center||Kansas City, Kansas 66160-7353|